Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 387 of 1,261

  1. US 10828414

    Magnetic filtration devices and methods related thereto

    The Regents of the University of California · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

  2. US 10829427

    Naphthoquinones, pro-drugs, and methods of use thereof

    The Board of Regents of the University of Texas System · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

  3. US 10828326

    Compositions and methods for treating and preventing venom related poisoning

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

  4. US 10829485

    ATF6 inhibitors and uses thereof

    BLACK BELT TX LTD · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

  5. US 10828289

    Hair follicle stem cell activation and hair growth

    The Regents of the University of California · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

  6. US 10829465

    Highly purified pharmaceutical grade tasimelteon

    VANDA PHARMACEUTICALS INC. · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

  7. US 10828315

    Targeted therapeutics

    Madrigal Pharmaceuticals, Inc. · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

  8. US 2020345623

    METHODS OF SCAR PREVENTION AND/OR TREATMENT

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Nov 5, 2020 · Expires Oct 31, 2040

    granted

  9. US 10822299

    Compounds and methods for hematopoietic regeneration

    The Regents of the University of California · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted

  10. US 10821178

    Methods of treating biofilm infections comprising administering inhibitors of myeloid-derived suppressor cells

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted

  11. US 10822421

    Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R)

    Five Prime Therapeutics, Inc. · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted

  12. US 10821146

    Powder formulation having a function of enhancing immunity and method for preparing the same

    INFINITUS (CHINA) COMPANY LTD. · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted

  13. US 10821092

    Viscous topical ocular formulations

    Encompass Development, Inc. · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted

  14. US 10820615

    Powder formulation having a function of enhancing immunity and method for preparing the same

    INFINITUS (CHINA) COMPANY LTD. · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted

  15. US 10822387

    Binding-triggered transcriptional switches and methods of use thereof

    The Regents of the University of California · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted

  16. US 10822422

    Antibodies against TL1a and uses thereof

    TEVA PHARMACEUTICALS AUSTRALIA PTY LTD · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted

  17. US 10821103

    Substituted pyridinone-containing trycyclic compounds, and methods using same

    ARBUTUS BIOPHARMA CORPORATION · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted

  18. US 10822427

    Anti-CSPG4 fusions with interferon for the treatment of malignancy

    The Regents of the University of California · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted

  19. US 10822316

    3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

    Valo Early Discovery, Inc. · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted

  20. US 10822353

    Dithio ETP derivatives

    The Regents of the University of California · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted

  21. US 10822378

    Mutated structural protein of a parvovirus

    Ludwig-Maximilians-Universitat Munchen · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted

  22. US 10821099

    Use of tradipitant in motion sickness

    VANDA PHARMACEUTICALS INC. · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted

  23. US 10822369

    Compounds and methods for the modulation of proteins

    Ionis Pharmaceuticals, Inc. · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted

  24. US 10822340

    Substituted imidazolopyrazine compounds and methods of using same

    The Regents of the University of California · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.